Wave Life Sciences, Inc. (WVE)
Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company’s medicines platform, PRISM combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, a GalNAc-conjugated RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; WVE-007, a GalNAc-conjugated small interfering RNA designed to silence INHBE mRNA targeting obesity; WVE-008, a GalNAc-conjugated RNA editing oligonucleotide for the treatment of liver disease; WVE-N531, an exon splicing oligonucleotide for the treatment of Duchenne muscular dystrophy; and WVE-003, an allele-selective oligonucleotide for the treatment of Huntington’s disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was founded in 2012 and is based in Singapore.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Wave Life Sciences Ltd.
No splits on record
Nothing in WVE's public trading history: no forward or reverse split has affected the share count.
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Revenue | $42.73M | $108.3M | $113.31M | $3.65M | $40.96M | $20.08M | $15.98M | $14.41M | $3.7M | $1.49M | $152K | $0 | $0 |
| YoY Growth | -60.5% | -4.4% | 3005.1% | -91.1% | 104.0% | 25.6% | 10.9% | 289.1% | 149.4% | 877.0% | - | - | - |
| Cost of Revenue | $8.85M | $0 | $0 | $0 | $0 | $130.94M | $175.43M | $134.43M | $79.31M | $393K | $9.06M | $2.4M | $4.61M |
| Gross Profit | $33.88M | $108.3M | $113.31M | $3.65M | $40.96M | -$110.87M | -$159.45M | -$120.01M | -$75.61M | $1.09M | -$8.9M | -$2.4M | -$4.61M |
| Gross Margin | 79.3% | 100.0% | 100.0% | 100.0% | 100.0% | -552.2% | -997.6% | -832.6% | -2041.2% | 73.5% | -5858.6% | - | - |
| Research and Development | $182.78M | $159.68M | $130.01M | $115.86M | $121.88M | $130.94M | $175.43M | $134.43M | $79.31M | $40.82M | $9.06M | $2.4M | $1.92M |
| Selling, General, and Administrative | $75.33M | $59.02M | $51.29M | $50.51M | $46.1M | $42.51M | $48.87M | $39.51M | $26.98M | $15.99M | $10.39M | $3M | $1.65M |
| Other | -$8.85M | $0 | $0 | $0 | $0 | -$130.94M | -$175.43M | $9.55M | -$331K | -$50K | $56K | $261K | $37K |
| Total Operating Expenses | $249.26M | $218.71M | $181.3M | $166.37M | $167.98M | $42.51M | $48.87M | $173.94M | $106.28M | $56.81M | $19.45M | $5.39M | $3.57M |
| Operating Income (EBIT) | -$215.38M | -$110.4M | -$68M | -$162.72M | -$127.02M | -$153.38M | -$208.32M | -$159.52M | -$102.58M | -$55.33M | -$19.3M | -$5.39M | -$3.57M |
| Operating Margin | -504.1% | -101.9% | -60.0% | -4459.3% | -310.1% | -763.9% | -1303.4% | -1106.7% | -2769.4% | -3725.7% | -12696.1% | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $16K | - | $22K | $6K | $337K | $86K | $12K | $0 |
| Interest Income | $10.48M | $0 | $0 | $0 | $30K | $0 | - | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | $11.01M | $13.39M | $9.81M | $1.58M | $4.57M | $2.63M | $14.68M | $12.94M | $1.25M | $542K | $142K | $249K | -$74K |
| Income Before Tax (EBT) | -$204.38M | -$97.01M | -$58.19M | -$161.14M | -$122.45M | -$150.75M | -$193.64M | -$146.58M | -$101.33M | -$54.78M | -$19.16M | -$5.14M | -$3.65M |
| Income Tax Expense | $0 | $0 | -$677K | $681K | -$204K | -$841K | $0 | $69K | $708K | $616K | $44K | $84K | -$330K |
| Net Income | -$204.38M | -$97.01M | -$57.51M | -$161.82M | -$122.25M | -$149.91M | -$193.64M | -$146.65M | -$102.03M | -$55.4M | -$19.2M | -$5.23M | -$3.32M |
| Net Income Margin | -478.3% | -89.6% | -50.8% | -4434.7% | -298.4% | -746.7% | -1211.5% | -1017.4% | -2754.7% | -3730.7% | -12631.6% | - | - |
| Supplementary Data | |||||||||||||
| EPS | -1.21 | -0.70 | -0.54 | -2.05 | -2.36 | -3.82 | -5.30 | -5.06 | -3.85 | -2.43 | -0.89 | -0.25 | -0.93 |
| Diluted EPS | -1.21 | -0.70 | -0.54 | -2.05 | -2.36 | -3.82 | -5.30 | -5.06 | -3.85 | -2.43 | -0.89 | -0.25 | -0.93 |
| Weighted Average OS | 168.65M | 138.28M | 106.10M | 78.86M | 51.83M | 39.23M | 33.87M | 28.97M | 26.51M | 22.80M | 21.55M | 20.93M | 3.55M |
| EBITDA | -$195.53M | -$88.34M | -$48.98M | -$151.03M | -$112.61M | -$143.39M | -$199.12M | -$153.94M | -$100.24M | -$54.94M | -$18.56M | -$5.11M | -$3.26M |
| EBITDA Margin | -457.6% | -81.6% | -43.2% | -4138.9% | -274.9% | -714.2% | -1245.8% | -1068.0% | -2706.2% | -3699.4% | -12211.8% | - | - |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Assets | |||||||||||||
| Current Assets | |||||||||||||
| Cash and Cash Equivalents | $602.07M | $302.08M | $200.35M | $88.5M | $150.56M | $184.5M | $147.16M | $174.82M | $142.5M | $150.29M | $161.22M | $1.05M | $439K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $602.07M | $302.08M | $200.35M | $88.5M | $150.56M | $184.5M | $147.16M | $174.82M | $142.5M | $150.29M | $161.22M | $1.05M | $439K |
| Accounts Receivable | $1.28M | $1.42M | $21.09M | $0 | $0 | $30M | $20M | $10M | $1M | $0 | $0 | $200K | $95K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $167K | $0 |
| Other Current Assets | $3.08M | $7.35M | $4.02M | $2.11M | $5.42M | $5.11M | $8.69M | $10.87M | $0 | $1.7M | $164K | $136K | $170K |
| Total Current Assets | $614.81M | $320.39M | $235.37M | $98.54M | $162.56M | $230.04M | $185.48M | $202.27M | $150.49M | $151.99M | $161.38M | $1.49M | $779K |
| Long-Term Assets | |||||||||||||
| Property, Plant & Equipment Net | $19.86M | $28M | $35.72M | $44.13M | $40.64M | $45.43M | $54.47M | $39.93M | $27.33M | $8.61M | $2.79M | $1.27M | $1.38M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $3.81M | $0 | $0 | $0 | $0 | $3.65M | $33.65M | $53.63M | $3.61M | $3.6M | $1.05M | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $560K | $192K | $182K | $160K |
| Other Long-Term Assets | $16K | $3.81M | $3.85M | $3.72M | $3.8M | $115K | $10.66M | $111K | $411K | $3.65M | $1.06M | $0 | $0 |
| Total Long-Term Assets | $23.68M | $31.81M | $39.58M | $47.85M | $44.44M | $49.2M | $98.77M | $93.67M | $31.36M | $12.82M | $4.04M | $1.45M | $1.54M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $638.5M | $352.21M | $274.95M | $146.39M | $207.01M | $279.24M | $284.25M | $295.94M | $181.84M | $164.81M | $165.42M | $2.94M | $2.32M |
| Liabilities | |||||||||||||
| Current Liabilities | |||||||||||||
| Accounts Payable | $15.7M | $16.26M | $12.84M | $16.91M | $7.28M | $13.79M | $9.07M | $13.09M | $7.6M | $4.94M | $2.81M | $125K | $176K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $3.71M | $3.24M | $1.16M | $0 | $0 | $0 | $0 | $9.6M |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $44.44M | $65.97M | $150.06M | $31.56M | $37.1M | $91.56M | $89.65M | $100.94M | $2.71M | $2.71M | $591K | $152K | $219K |
| Other Current Liabilities | $18.08M | $15.36M | $14.06M | $12.29M | $10.18M | $2.97M | $7.52M | $6.47M | $1.33M | $3.44M | -$238K | $177K | $52K |
| Total Current Liabilities | $95.06M | $110.95M | $186.44M | $71.52M | $64.2M | $121.04M | $118.15M | $130.04M | $19.62M | $12.15M | $3.82M | $882K | $10.05M |
| Long-Term Liabilities | |||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $9.25M | $3.09M | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $7.8M | $6.1M | $15.6M | $79.77M | $77.48M | $41.48M | $63.47M | $68.16M | $5.61M | $8.31M | $7.8M | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $68.16M | $1.37M | $16K | $78K | $0 | $0 |
| Other Long-Term Liabilities | $0 | $7.87M | $7.87M | $8.06M | $7.87M | $474K | $1.72M | $5.9M | $10.61M | $1.59M | $163K | $29K | $36K |
| Total Long-Term Liabilities | $17.2M | $31.74M | $48.88M | $119.96M | $110.31M | $67.55M | $94.49M | $92.55M | $22.41M | $17.79M | $8.12M | $29K | $36K |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $112.27M | $142.69M | $235.32M | $191.48M | $174.51M | $188.59M | $212.64M | $222.59M | $42.03M | $29.95M | $11.93M | $911K | $10.09M |
| Stockholders' Equity | |||||||||||||
| Preferred Stock | $7.87M | $0 | $0 | $0 | $0 | $7.87M | $7.87M | $0 | $0 | $0 | $0 | $7.87M | $2.02M |
| Common Stock | $1.62B | $1.18B | $935.37M | $802.83M | $749.85M | $694.09M | $539.55M | $375.15M | $310.04M | $215.6M | $185.34M | $9.97M | $638K |
| Retained Earnings | -$1.33B | -$1.12B | -$1.02B | -$967.34M | -$805.51M | -$683.27M | -$533.36M | -$339.72M | -$192.51M | -$90.48M | -$35.08M | -$15.88M | -$10.65M |
| Comprehensive Income & Other | -$250K | -$262K | -$124K | -$29K | $181K | $389K | $267K | $153K | $116K | -$291K | $41K | $56K | $225K |
| Other Stockholders' Equity | $235.99M | $156.19M | $129.11M | $119.41M | $88.16M | $79.84M | $65.42M | $37.92M | $22.29M | $9.74M | $3.22M | $7.93M | $2.25M |
| Total Equity | $526.23M | $209.51M | $39.63M | -$45.09M | $32.5M | $90.65M | $71.61M | $73.35M | $139.81M | $134.86M | $153.49M | $2.03M | -$7.76M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $638.5M | $352.21M | $274.95M | $146.39M | $207.01M | $279.24M | $284.25M | $295.94M | $181.84M | $164.81M | $165.42M | $2.94M | $2.32M |
| Supplementary Data | |||||||||||||
| Total Debt | $17.77M | $25.4M | $32.12M | $37.61M | $29.92M | $29.3M | $32.55M | $10.4M | $3.45M | $78K | $140K | $0 | $9.6M |
| Net Debt | -$584.3M | -$276.67M | -$168.23M | -$50.88M | -$120.65M | -$155.19M | -$114.61M | -$164.42M | -$139.05M | -$150.22M | -$161.08M | -$1.05M | $9.16M |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Operating Activities | |||||||||||||
| Net Income | -$204.38M | -$97.01M | -$57.51M | -$161.82M | -$122.25M | -$149.91M | -$193.64M | -$146.65M | -$102.03M | -$55.4M | -$19.2M | -$5.23M | -$3.32M |
| Depreciation & Amortization | $8.85M | $8.66M | $9.21M | $10.11M | $9.84M | $9.98M | $9.2M | $5.58M | $2.15M | $784K | $594K | $281K | $276K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | -$12.64M | -$9.14M | $0 | $44K | $774K | -$874K | $36K | $84K | -$330K |
| Stock-Based Compensation | $0 | $13.14M | $9.79M | $17.19M | $16.41M | $14.3M | $19.51M | $15.6M | $12.14M | $6.85M | $4.02M | $0 | $0 |
| Changes in Working Capital: | |||||||||||||
| Accounts Receivable | $146K | $19.66M | -$21.09M | $0 | $30M | $20M | $10M | -$59M | -$1M | $0 | $193K | -$129K | -$102K |
| Inventory | $0 | $0 | $0 | $0 | $2.04M | $4.61M | $0 | -$4.08M | $0 | $0 | $242K | $398K | $0 |
| Accounts Payable | -$561K | $3.42M | -$3.76M | $9.35M | -$6.57M | $5.12M | -$3.5M | $4.94M | $3.89M | $3.37M | $1.65M | $9K | -$152K |
| Other Working Capital | -$16.52M | -$98.91M | $43.93M | -$2.63M | -$18.46M | -$20.08M | -$29.81M | $160.53M | -$4.19M | $12.84M | -$152K | $152K | $81K |
| Total Working Capital Change | -$16.94M | -$75.82M | $19.08M | $6.72M | $7.01M | $9.65M | -$23.3M | $102.39M | -$299K | $16.21M | $1.93M | $430K | -$173K |
| Other Non-Cash Items | $24.97M | $0 | $0 | $12K | $12.64M | $9.14M | $0 | $183K | $3.59M | $565K | $88K | -$6K | -$6K |
| Net Cash from Operating | -$187.49M | -$151.03M | -$19.43M | -$127.78M | -$88.99M | -$115.98M | -$188.23M | -$22.86M | -$83.67M | -$31.87M | -$12.53M | -$4.43M | -$3.55M |
| Investing Activities | |||||||||||||
| Capital Expenditures | -$718K | -$938K | -$1.11M | -$1.36M | -$560K | -$1.34M | -$3.92M | -$9.94M | -$18.89M | -$5.57M | -$1.86M | -$590K | -$47K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $4K | $3K | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | -$75.04M | $0 | $0 | $0 | $0 | $0 | -$2.6M | -$1.05M | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $75.04M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $106K | $0 | $0 | $0 | -$9.94M | -$9K | -$2.6M | -$1.05M | $333K | $0 |
| Net Cash from Investing | -$718K | -$938K | -$1.11M | -$1.25M | -$560K | -$1.34M | -$3.92M | -$9.94M | -$18.9M | -$8.16M | -$2.91M | -$257K | -$47K |
| Financing Activities | |||||||||||||
| Debt Repaid | - | - | - | - | - | - | - | $16K | $62K | $62K | $126K | - | - |
| Common Stock Issuance | $488.24M | $236.18M | $131.28M | $52.33M | $54.97M | $153.63M | $161.79M | $60M | $93.51M | $30M | $113.08M | $5.58M | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $17.71M | $1.26M | $14.86M | $858K | $912K | $2.61M | $5.11M | $927K | -$817K | $112K | $34K | $3.67M |
| Net Cash from Financing | $488.24M | $253.89M | $132.53M | $67.19M | $55.83M | $154.54M | $164.4M | $65.09M | $94.37M | $29.12M | $175.59M | $5.62M | $3.67M |
| Forex Effect | $12K | -$138K | -$95K | -$210K | -$208K | $122K | $114K | $37K | $403K | -$14K | $15K | -$327K | -$14K |
| Net Change in Cash | $300.04M | $101.79M | $111.89M | -$62.06M | -$33.93M | $37.34M | -$27.64M | $32.33M | -$7.79M | -$10.93M | $160.17M | $609K | $60K |
| Supplementary Data | |||||||||||||
| Operating Cash Flow | -$187.49M | -$151.03M | -$19.43M | -$127.78M | -$88.99M | -$115.98M | -$188.23M | -$22.86M | -$83.67M | -$31.87M | -$12.53M | -$4.43M | -$3.55M |
| Capital Expenditure | -$718K | -$938K | -$1.11M | -$1.36M | -$560K | -$1.34M | -$3.92M | -$9.94M | -$18.89M | -$5.57M | -$1.86M | -$590K | -$47K |
| Free Cash Flow | -$187.49M | -$151.96M | -$20.55M | -$129.14M | -$89.55M | -$117.32M | -$192.15M | -$32.8M | -$102.56M | -$37.44M | -$14.38M | -$5.02M | -$3.6M |
| Cash at Beginning | $302.08M | $204.05M | $92.16M | $154.22M | $188.15M | $150.81M | $178.44M | $146.11M | $150.29M | $161.22M | $1.05M | $439K | $379K |
| Cash at End | $602.07M | $305.84M | $204.05M | $92.16M | $154.22M | $188.15M | $150.81M | $178.44M | $142.5M | $150.29M | $161.22M | $1.05M | $439K |